Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 89.30
-1.30 (-1.43%)
Aug 28, 2026, 1:30 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 13.23 billion as of August 28, 2026. Its market cap has decreased by -29.96% in one year.
Market Cap
13.23B
Enterprise Value
11.08B
Revenue
10.12B
Ranking
n/a
PE Ratio
11.61
Stock Price
89.30
ChartMarket Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 13.23B, an increase of 469.58%. That is a compound annual growth rate of 5.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 13.23B | -29.41% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 25.19B |
| TTY Biopharm Company | 19.37B |
| Synmosa Biopharma | 16.11B |
| ScinoPharm Taiwan | 15.06B |
| YungShin Global Holding | 14.92B |
| Handa Pharmaceuticals | 12.81B |
| Foresee Pharmaceuticals | 12.60B |
| Standard Chemical & Pharmaceutical | 10.11B |